Orotic aciduria is a rare autosomal recessive disease in man due to a deficiency of orotate phosphoribosyltransferase (EC 2.4.2.10; orotidine-5'-phosphate: pyrophosphate phosphoribosyltransferase) and oro-
carboxylase from homozygous mutant cells was more thermolabile and exhibited at different electrophoretic mobility when compared to the enzyme from normal cells; orotidine-5'-phosphate decarboxylase from one heterozygous cell strain exhibited an intermediate thermplability while the other heterozygote displayed a thermal inactivation curve indistinguishable from normal. The enzyme from both normal and mutant cells exhibited bi.
phasic kinetics with the same apparent Michaelis constants. These data suggest that the molecular defect in the enzyme of this patient with orotic aciduria is due to a mutation in a gene that affects the structure of either orotate phosphoribosyltransferase or orotidine-5'-phosphate decarboxylase and cannot be Attributed to a mutation in a regulatory gene, as previously suggested.
Enzymatic defects of pyrimidine biosynthesis in eukaryotic organisms are exceedingly rare and, to date, are found only in a group of disorders that have in common the excretion of large quantities of orotic acid. In man the primary disorder in this group is hereditary orotic aciduria, an autosomal recessive genetic disease, characterized by megaloblastic anemia, leukopenia, retarded growth and development, and an increased urinary excretion of orotic acid (1, 2) . Biochemically, this disorder is characterized by either of two phenotypes: type I is most prevalent and exhibits deficient or decreased activity of orotate phosphoribosyltransferase (OPRT; EC 2.4.2.10; orotidine-5'-phosphate:pyrophosphate phosphoribosyltransferase) and orotidine-5'-phosphate decarboxylase (ODC; EC 4.1.1.23; orotidine-'-phosphate carboxy-lyase), the enzymes that catalyze the conversion of orotic acid to uridine-5'-phosphate (3) ; type II is -characterized by a deficiency only in orotidine-5'-phosphate decarboxylase (4) .
The genetic defect in hereditary orotic aciduria was proposed to be a consequence of a mutation in a regulator genet and has been cited as one of the few examples of such a defect Abbreviations: OPRT, orotate phosphoribosyltransferase; ODC. orotidine-5'-phosphate decarboxylase; OMP, orotidine-5'-monophosphate. * To whom reprint requests should be addressed. t Defined by us, but not by the authors cited, as a gene that controls the synthesis of an enzyme but has no effect on its structure. 3031 in man (5) . This proposal was based on several observations. (i) The double enzyme defect was difficult to explain as a structural gene mutation. Alternatively, some mutations in bacteria that affected the regulation of enzyme expression were known to reduce the levels of two or more enzymes in a pathway (6) . In addition, OPRT and ODC levels were known to be subject to genetic control in bacteria (7); more recently this type of control has been demonstrated in yeast (8) .
(ii) In erythrocytes from heterozygotes, OPRT and ODC levels were often substantially less than 50% of normal. This was consistent with a trans dominant effect characteristic of some regulatory mutations in prokaryotic cells (6) . More recently, Pinsky and Krooth noted that the addition of 6-azauridine to normal cells in culture resulted in a modest increase in the activity of OPRT and ODC, whereas a marked increase in the activity of both enzymes was observed after the addition of this pyrimidine analog to cells cultured from a patient with orotic aciduria (9) . Although the mechanism responsible for this effect in either cell type was not clearly elucidated, the findings were consistent with the hypothesis that 6-azauridine, or a metabolic intermediate accumulating as the result of the presence of this analog, was capable of inactivating the product of a regulator gene that was presumably preventing the synthesis of these enzymes in the mutant cells (10) .
Although these observations in hereditary -orotic aciduria were consistent with a regulatory defect, they could also be accounted for by a mutation in a structural gene(s) coding for one of the involved enzymes, and definitive data were not available to differentiate between these possibilities. In the present study, we have used the 6-azauridine-augmented activity of ODC in fibroblasts in order to compare the physicochemical properties of this enzyme from normal subjects and from a patient with hereditary orotic aciduria. The results of these experiments suggest that the double enzyme defect in hereditary orotic aciduria is due to a mutation in either one or both of the structural genes coding for the two affected enzymes. A preliminary report of these findings has been presented (11) .
MATERIALS AND METHODS
Materials. [7- '4C]Orotic acid (10.2 mCi/mmole) and [7- 14C]orotidine-5'-monophosphate (21 mCi/mmole) were from New England Nuclear Corp.; 6-azauridine and tetrasodium 5-phosphoribosyl-l-pyrophosphate were from Sigma Chemical Co.; 6-azauridine-5'-monophosphate was from Calbiochem; Sephadex G-25 was from Pharmacia; acrylamide, N,N'-methylenebisacrylamide, and N,N,N',N'-tetramethylethylenediamine were from Eastman Kodak Co.; tissue culture materials were from Grand Island Biological Co.; and 10% agarose was from Bio-rad. All other materials were the highest quality available and were purchased commercially.
Cell Culture. Primary cultures of skin fibroblasts were obtained from explant cultures of punch biopsies from the inner forearm of normal subjects, a subject homozygous for hereditary orotic aciduria (strain 237) (12) , and her heterozygous parents (father, strain 241; mother, strain 242). The cultures were routinely maintained in a tissue culture medium described by Silagi et al. (13) and modified to contain 20% (v/v) fetal-calf serum. Only cells between passages 2 and 15 were used in the experiments. Fibroblasts were routinely grown for 6-8 days after passage before use in experiments; control experiments indicated that OPRT and ODC activities were stable between 6 and 9 days after passage. Cultures were fed every 3-4 days, and both normal and mutant cells were refed, with Eagle's Minimal Essential Medium containing 10% fetal-calf serum, 2 days before use.
Preparation of Cell Lysates. Cell lysates from confluent monolayers were prepared as reported (14) . After centrifugation at 600 X g to remove cellular debris, the lysates were passed through individual Sephadex G-25 columns with a bed volume of 1.5 ml and a void volume of 0.6 ml. Samples (200 Il) of lysates were layered onto the top of the columns and allowed to enter the Sephadex; 600 ul of 10 mM Trise HCl (pH 7.4) was added and the column was allowed to drain.
The desalted lysates were then collected by elution with 300 M1 of the same buffer. The desalting procedure had no apparent effect on the specific activity of either enzyme.
Enzyme Assays. ODC was assayed according to Kelley and Beardmore (15) . The assay for OPRT (14) was modified to measure 14CO2 instead of the formation of orotidine-5'-monophosphate (OMP). The reaction was initiated by addition of [7-14C] orotic acid, and the tubes were incubated at 370 for 60 min. OPRT activity was stopped by addition of 100 ,ul of 0.1 M EDTA (pH 7.4), containing 50 ,ul of a partially purified preparation of ODC from human erythrocytes. The addition of excess ODC converted all the OMP formed in the initial reaction mixture to uridylic acid and 14CO2 during an additional 15-min incubation; the reaction was terminated by injection of 200 MAl of 3.5 M perchloric acid. This modification eliminated the problem of residual OPRT activity present in the partially purified ODC preparation. Protein was determined by the method of Lowry et al. (16) .
Enzyme Kinetics. Lysates used in the kinetic studies of ODC were prepared in 10 mM Tris HC1 (pH 7.4) with 50 mM EDTA and assayed at a final concentration of 25 mM EDTA. Under these conditions there was no change in initial velocity and less than 0.5% of the OMP in the reaction mixture was degraded by 5'-nucleotidase to orotidine. The release of 14CO2 was proportional to time and protein concentration.
Polyacrylamide Gel Electrophoresis of ODC was performed in a modified multiphasic buffer system (system B) described by Rodbard and Chrambach (17) . Gels of various concentrations of acrvlamide, but with a constant 5% crosslinking, were made by mixing 4.5 ml of acrylamide, 5.0 ml of separation gel buffer (0.375 M Tris, 0.16 M HCl, pH 8.55), and 0.5 mg/ml). The resultant solution was degassed for 15 min with stirring. N,N,N',N'-Tetramethylethylene diamine (15 ul) was added, and 1.1 ml of the acrylamide solution was gently layered into gel tubes (70 mm X 5 mm inner diameter); the gels were then polymerized at room temperature for 60 min. The gels were first subjected to electrophoresis in separation gel buffer for 90 min at 170 at a constant current of 2.5 mA per gel. A stacking gel was added by layering 0.25 ml of a 4% acrylamide solution, made with stacking gel buffer (45 mM Tris, 32 mM\ H3PO4, pH 7.1), on top of the separation gel and polymerizing for 60 min. The gels were placed in the electrophoresis chamber, and anode (62 mM Tris, 50 mM HCl, pH 7.6) and cathode (42 mM Tris, 46 mM glycine, pH 9.0) buffers were added. Lysates (50-100 Al) containing bromphenol blue (2 ,ug/ml) as the tracking dye and sucrose (20%) to increase the lysate density were gently layered on top of the gels, and the gels were subjected to electrophoresis at 170 with a constant current of 2.5 mA per gel. Electrophoresis was stopped when the tracking dye migrated to within 5 mm of the end of the gels (about 90 min). The gels were removed from the tubes; dye fronts and gel lengths were measured, and the gels were frozen at -70°. The frozen gels were cut into 1.2-mm slices, placed in assay tubes containing 100 M1A of 10 mM Trise HCl pH 7.4, and assayed for ODC activity.
Determination of the Stokes Radius. The Stokes radius of ODC was determined from the chromatographic behavior on a 10% agarose column. The partition coefficient (Kay) of ODC was determined by the method of Laurent and Killander (18) , with ovalbumin, alcohol dehydrogenase, and catalase as standards. Values of the Stokes radius of the standards were taken from published reports (19) . The inverse error function complement of the column partition coefficient (erfc -l) was derived from the Kav as described by Ackers (20 (Table 2) . Similar results were found for OPRT from the mutant fibroblasts (Table 2 ). Thus, the low level of activity in mutant fibroblasts does not appear to be due to a low level of affinity for orotic acid by another phosphoribosyltransferase. In addition, the low levels of OPRT were not due to an occult infection since there was neither visible infection nor mycoplasma, as judged by agar cultures and autoradiography (23) .
Effect of 6-Azauridine on Orotate Phosphoribosyltransferase and Orotidine-'-Phosphate Decarboxylase. Pinsky and Krooth (9) observed that the addition of 6-azauridine to cultured fibroblasts led to increased activity of both OPRT and ODC. The effect of 6-azauridine on the levels of OPRT and ODC activity in desalted fibroblast lysates from normal and mutant subjects is shown in Fig 1. The cultivation of normal cells in 0.1 mM 6-azauridine for 16-18 hr led to a 2.5-and 3-fold increase in the activity of OPRT and ODC, respectively. Under identical conditions, strain 241 exhibited a 3-fold increase in OPRT and an 8-fold increase in ODC activity, whereas strain 242 showed a 3-fold increase in OPRT but no increase in ODC. ODC from homozygous mutant cells exhibited an increase in activity of about 9-fold to a mean activity of 0.85, while no apparent increase was seen in OPRT activity in response to 6-azauridine. This increase in ODC activity observed in normal and mutant cells enabled us to investigate some of the properties of this enzyme from each cell strain. Because of the low activity of OPRT in fibroblasts from the patient with hereditary orotic aciduria, the majority of subsequent experiments deal only with ODC.
Thermal Inactivation of Orotidine-5'-Phosphate Decarboxylase. Fig 2 illustrates 2(left) . Thermalinactivation curvesof ODC from lysates of normal, heterozygous, and mutant fibroblasts. Samples (600 2)) of desalted lysates from fibroblasts grown in the presence of 0.1 mM 6-azauridine for 16 hr were heated at 57o1 At appropriate times, 50-iAl samples (in duplicate) were removed and placed in tubes in an ice bath. Immediately after they were heated for 8 min, the samples were assayed at 370 for 15 mm. Each point is the mean of five to six experiments (+ 1 SD). See Fig. 1 (Fig 4) . Thus, ODC from the mutant cells appeared to differ from the normal enzyme in net charge. Lysates were prepared as described in Materials and Methods. About 100 1Ag of each lysate was loaded onto the top of polyacrylamide gels (5% crosslink) ranging in concentration from 4-16%. The gels were subjected to electrophoresis at 2.5 mA per gel, fractionated, and assayed. Each point is the mean of four determinations (i SD). Recoveries were similar to those in Fig. 3 (26) and calf brain (27) . Presumably, alteration in the structure of either enzyme could affect the net charge and stability of the complex. Therefore, it is possible that the altered properties of ODC are due to a mutation in the structural gene coding for OPRT. Our observation that OPRT activity remains at control levels in mutant fibroblasts grown in 6-azauridine while ODC activity increased 9-fold provides meager evidence for this interpretation. The failure of ODC activity in mutant cells to attain normal control activity, as reported by Pinsky and Krooth (9), would be explicable in terms of a destabilization of the complex.
A comparison of our data with those reported earlier by Pinsky and Krooth in cells from another unrelated subject with hereditary orotic aciduria (9) reveals a substantial difference in the level of both OPRT and ODC activity attained after incubation with azauridine. This finding raises the possibility that genetic heterogeneity may exist within the group of subjects with type I orotic aciduria. Perhaps, the differences observed in the two heterozygous cell strains with regard to the effect of azauridine and thermal inactivation of OPRT and ODC are also a reflection of genetic heterogeneity.
